News
Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...
Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...
Artificial intelligence can help urologists and oncologists make treatment recommendations that are objective and evidence-based.
The urology imaging systems market is projected to grow at a CAGR of 4% in the next five years. This growth is driven by the ...
“This test could turn the tide on prostate cancer,” said Prof. Ros Eeles, who led the study. “We have shown that a relatively simple, inexpensive spit test to identify men of European heritage at ...
A prostate cancer patient said he was "delighted" to be back in his own bed the same day as undergoing major robotic surgery.
It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...
Discover a recent study that found that microultrasonography-guided biopsy could provide an alternative to MRI.
As per Vantage Market Research, the Global Fusion Biopsy Market has been rapidly growing due to the advancements in medical imaging technology, the increasing prevalence of prostate cancer, and the ...
In this video, Alan Dow, MD, MSHA, FACP, discusses evolving cancer screening guidelines and the controversies surrounding some of them. The first screening update involved pancreatic cancer.
An at-home saliva test that assesses genetic risk of prostate cancer may be more accurate than PSA level or MRI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results